JGL reports 16 percent gross profit growth with 38.3 million euro EBITDA

Croatian pharmaceutical company JGL reported a 16 percent increase in gross profit and an EBITDA of 38.3 million euros. The company maintains a strategy of prioritizing revenue generation in international markets.